Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Shire teams up with Microsoft and EURORDIS for rare disease project

Will work to accelerate the time to diagnosis for children

Shire

Shire has formed a strategic alliance with Microsoft and the European rare diseases patient group organisation EURORDIS to accelerate the time it takes for children with rare diseases to receive a diagnosis.

On average its rare disease patients – around half of whom are children – have to wait for five years before they receive the correct diagnosis for their condition.

To help tackle this diagnostic lag and its attendant health and wellbeing impact, the partners’ new Global Commission will develop an “actionable roadmap”, with technology planned to play a leading part in the work.

The Commission will be jointly led by Shire’s CEO Flemming Ornskov, Microsoft’s chief medical officer Simon Kos and Eurordis CEO Yann Le Cam. In turn they will bring together a dedicated group that will include technology innovators, patient advocates and healthcare providers to focus on the challenge.

Microsoft’s Kos said: “We have an opportunity to harness the power of technology to tackle this painful issue that has affected so many. We’re seeking innovative ways to integrate emerging technologies into our efforts, which will play a critical role as we strive to impact the diagnosis journey.

“Microsoft is committed to this mission and I believe the Global Commission’s wide range of expertise, along with the infusion of technology, will change the state of rare disease diagnosis.”

The roadmap will aim to address areas such as how best to identify and diagnose patients, helping patients and their families be more active in their health care, and providing high-level policy guidance on health outcomes in rare diseases.

Shire’s Ornskov said: “As a physician with training in paediatrics, I’ve seen firsthand the devastating effect not having an accurate diagnosis can have on patients, their families, as well as on the health care providers working to help them. Accelerating the time to diagnosis is critical to improving outcomes for patients and health systems.

“This Global Commission is passionate about bringing forward new and personalised solutions in diagnostics and I’m confident our work will help to transform the lives of children living with a rare disease.”

The Global Commission will beginning its work shortly and expects to publish the roadmap of its findings in early 2019.

20th February 2018

From: Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes....

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics